قالب وردپرس درنا توس
Home / Health / A US study found that cannabis lowers insulin levels in overweight type 2 diabetics

A US study found that cannabis lowers insulin levels in overweight type 2 diabetics



Adipose adults who consumed marijuana had significantly less fasting insulin than those who did not use cannabis, according to a recent US study.

Cannabis lowers insulin levels in obese and overweight type 2 diabetics, according to a new study. [19659003] Overweight adults in the US who consumed marijuana had significantly lower fasting insulin than those who did not use cannabis. This was the result of a recent study. The US study concluded that marijuana use is associated with lower insulin levels during fasting in obese adults. Even adults who have frequently smoked cannabis in the past have lower levels of insulin during fasting.

The study involved 1

29,509 participants between the ages of 18 and 59 years. Among the participants, 32.7 percent were classified as overweight and 32.6 percent as obese. According to Steve Freed, the publisher of Diabetes in Control, all study participants were Type 2 diabetics.

Fasting insulin is a measurement that assesses the sensitivity of diabetics. High fasting insulin levels are a symptom of insulin resistance leading to type 2 diabetes.

Diabetes Canada recommends that cannabis be fatal to people with type 1 diabetes. According to a position paper from Diabetes Canada, cannabis use has been linked to diabetic ketoacidosis in type 1 diabetes. Diabetic ketoacidosis can lead to coma or death, because the blood sugar level is too high and too much ketone (acids that are produced by the breakdown of fat for energy).

Diabetes Canada recommends that individuals with Type 1 and Type 2 diabetes seek individual medical attention to guide cannabis use.

The US study found that the median fasting insulin was higher in adults who never consume marijuana than in current cannabis users (9.83 microunits / milliliter (. ΜU / ml) vs , 7.70 μU / ml).

In subjects with obesity, mean fasting insulin was 52 percent lower in those who consume marijuana less than four times a month than in people who never consume cannabis. According to the study, fasting insulin concentration was also lower among those who consume cannabis more frequently (eight or more times a month).

Participants who were previously overweight found fasting insulin concentrations in those who were not regular cannabis users, and those who had stopped within 12 months were no different from those who did not consume pot.

Cannabis use did not affect the insulin levels of people who were not overweight or obese, except in adults who used to drink marijuana. Among adults who used to drink marijuana less than four times a month but stopped one to ten years ago, 37 percent lower fasting insulin was reported than those who never consumed cannabis.

The study also examined the homeostasis model assessment of insulin resistance (HOMA-IR), a method for assessing insulin resistance from fasting glucose, and similarly low scores in participants using Potency drugs.

Want to stay up-to-date on developments in the cannabis world? Subscribe to the Cannabis Post newsletter for weekly insights into the industry about insiders and content across the entire Postmedia network.


Source link